NovaBridge Biosciences (FRA:0VY)

NovaBridge Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	254	67	143	325	3,207	2,717
Market Cap Growth	303.87%	-53.13%	-56.11%	-89.86%	18.02%	-
Enterprise Value	59	-130	-215	-208	2,564	2,546
Last Close Price	2.18	0.83	1.65	3.34	40.20	33.00
PE Ratio	-	-	-	-	-	46.08
PS Ratio	-	-	249.50	-223.95	263.21	14.07
PB Ratio	1.15	0.34	0.65	0.82	5.08	3.86
P/TBV Ratio	1.15	0.34	0.65	0.91	5.42	4.06
P/FCF Ratio	-	-	-	-	-	50.99
P/OCF Ratio	-	-	-	-	-	50.05
EV/Sales Ratio	-	-	-	-	210.43	13.18
EV/EBITDA Ratio	-	-	-	-	-	120.82
EV/EBIT Ratio	-	-	-	-	-	130.71
EV/FCF Ratio	-4.07	-	-	-	-	47.79
Debt / Equity Ratio	0.01	0.02	0.02	0.03	0.03	0.00
Debt / EBITDA Ratio	-	-	-	-	-	0.08
Debt / FCF Ratio	-	-	-	-	-	0.03
Net Debt / Equity Ratio	-0.87	-0.84	-1.27	-1.16	-0.91	-0.85
Net Debt / EBITDA Ratio	6.49	3.31	6.35	9.27	2.02	-28.38
Net Debt / FCF Ratio	13.24	1.59	2.10	5.31	4.15	-11.22
Asset Turnover	-	-	0.00	-	0.02	0.38
Quick Ratio	14.24	20.65	5.39	4.60	7.48	9.12
Current Ratio	14.47	20.90	5.67	4.78	7.66	9.28
Return on Equity (ROE)	-	-22.40%	-24.75%	-26.08%	-45.78%	14.06%
Return on Assets (ROA)	-	-11.05%	-6.38%	-4.73%	-21.69%	2.41%
Return on Invested Capital (ROIC)	-101.41%	-	-	-	-338.80%	34.43%
Return on Capital Employed (ROCE)	-13.30%	-25.20%	-15.80%	-11.00%	-41.60%	2.70%
Earnings Yield	-8.83%	-32.12%	-131.74%	-106.82%	-10.06%	2.17%
FCF Yield	-5.70%	-154.11%	-93.01%	-26.58%	-4.33%	1.96%
Buyback Yield / Dilution	-6.88%	2.45%	-0.86%	-8.63%	-11.11%	-2030.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.